Literature DB >> 8406890

Microtubule inhibitors block Cryptosporidium parvum infection of a human enterocyte cell line.

P M Wiest1, J H Johnson, T P Flanigan.   

Abstract

No effective therapy exists for Cryptosporidium parvum, a coccidial protozoan parasite that causes severe diarrhea in patients with AIDS. The role of microtubules in parasite invasion of host cells was investigated by incubating 10(7) oocysts with a HT 29.74 cell line for 24 h in the presence of microtubule-disrupting drugs. The number of parasites per 1,000 cells was reduced by 77% (P < 0.001, n = 4) from 182 +/- 3 in untreated cells to 42 +/- 4 in cells treated with 10(-4) M colchicine. Inhibition of C. parvum infection was concentration dependent. Similar results were seen with a second microtubular depolymerization agent, vinblastine. These data suggest that microtubules are important in host cell invasion by C. parvum and may represent targets for development of new therapeutic drugs for treatment of cryptosporidiosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406890      PMCID: PMC281249          DOI: 10.1128/iai.61.11.4888-4890.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

Review 1.  Enteropathogenic Escherichia coli.

Authors:  M S Donnenberg; J B Kaper
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 2.  Functions of microtubule-based motors.

Authors:  T A Schroer; M P Sheetz
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

3.  A comparison of HEp-2 cell invasion by enteropathogenic and enteroinvasive Escherichia coli.

Authors:  M S Donnenberg; A Donohue-Rolfe; G T Keusch
Journal:  FEMS Microbiol Lett       Date:  1990-05       Impact factor: 2.742

Review 4.  The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles.

Authors:  E Lacey
Journal:  Int J Parasitol       Date:  1988-11       Impact factor: 3.981

Review 5.  Cryptosporidiosis and isosporiasis in patients with AIDS.

Authors:  R Soave
Journal:  Infect Dis Clin North Am       Date:  1988-06       Impact factor: 5.982

6.  Inhibition of malaria parasite invasion into erythrocytes pretreated with membrane-active drugs.

Authors:  A A McColm; M Hommel; P I Trigg
Journal:  Mol Biochem Parasitol       Date:  1980-04       Impact factor: 1.759

7.  Asexual development of Cryptosporidium parvum within a differentiated human enterocyte cell line.

Authors:  T P Flanigan; T Aji; R Marshall; R Soave; M Aikawa; C Kaetzel
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Ultrastructural study of asexual development of Cryptosporidium parvum in a human intestinal cell line.

Authors:  T Aji; T Flanigan; R Marshall; C Kaetzel; M Aikawa
Journal:  J Protozool       Date:  1991 Nov-Dec

9.  In vitro screening of therapeutic agents against Cryptosporidium: hyperimmune cow colostrum is highly inhibitory.

Authors:  T Flanigan; R Marshall; D Redman; C Kaetzel; B Ungar
Journal:  J Protozool       Date:  1991 Nov-Dec

10.  The role of the cytoskeleton in the motility of coccidian sporozoites.

Authors:  D G Russell; R E Sinden
Journal:  J Cell Sci       Date:  1981-08       Impact factor: 5.285

View more
  8 in total

1.  Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblasts.

Authors:  M Jevon; C Guo; B Ma; N Mordan; S P Nair; M Harris; B Henderson; G Bentley; S Meghji
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  In vitro cultivation of cryptosporidium species.

Authors:  Michael J Arrowood
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

3.  Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells.

Authors:  Amna Hashim; Grace Mulcahy; Billy Bourke; Marguerite Clyne
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  The effect of microfilament inhibitor on the Cryptosporidium infection in vitro.

Authors:  J R Yu; S D Choi
Journal:  Korean J Parasitol       Date:  2000-12       Impact factor: 1.341

5.  Dicyclic and tricyclic diaminopyrimidine derivatives as potent inhibitors of Cryptosporidium parvum dihydrofolate reductase: structure-activity and structure-selectivity correlations.

Authors:  R G Nelson; A Rosowsky
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  Synthesis and evaluation of dinitroanilines for treatment of cryptosporidiosis.

Authors:  J W Benbow; E L Bernberg; A Korda; J R Mead
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

7.  Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.

Authors:  Amna Hashim; Marguerite Clyne; Grace Mulcahy; Donna Akiyoshi; Rachel Chalmers; Billy Bourke
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells.

Authors:  S J Upton; M Tilley; D B Brillhart
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.